Structural disease progression in PDE6-associated autosomal recessive retinitis pigmentosa
Carregando...
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
Citação
OPHTHALMIC GENETICS, v.39, n.5, p.610-614, 2018
Resumo
Background and objective: To evaluate the progression of retinitis pigmentosa (RP) caused by mutations in either PDE6A or PDE6B by measuring the progressive constriction of the hyperautofluorescent ring and shortening of the ellipsoid zone (EZ)-line width. Patients and methods: Fundus autofluorescence (FAF) and spectral-domain optical coherence tomography (SD-OCT) images were obtained from seven patients with autosomal recessive RP caused by mutations in either PDE6A or PDE6B. Measurements of the EZ line width on SD-OCT images and horizontal, vertical diameter, and ring area on FAF images were performed by two independent graders. The measurements of these four parameters were correlated with one another. Results: We observed that the EZ line width decreased by an average of 91 +/- 64 mu m per year, while the horizontal and vertical diameters decreased by 103 +/- 53 mu m and 92 +/- 49 mu m per year, respectively. The ring area decreased by a rate of 0.3 +/- 0.18 mm(2) per year. Progression rates were similar for the left eye. Conclusions: We observed a progressive loss of EZ line width and Short-wavelength fundus autofluorescence (SW-AF) ring constriction over time. These results may serve as reference for better prognostic prediction and patients selection for clinical trials promoting cone rescue.
Palavras-chave
Autosomal recessive, disease progression, PDE6A, PDE6B, retinitis pigmentosa
Referências
- BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1456, DOI 10.1001/archopht.1993.01090110014001
- Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1306, DOI 10.1001/archopht.122.9.1306
- BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4
- BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022
- Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001
- Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7
- Bittner AK, 2011, OPTOMETRY VISION SCI, V88, P1496, DOI 10.1097/OPX.0b013e3182348d0b
- Cabral T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10473-0
- Cai CX, 2014, INVEST OPHTH VIS SCI, V55, P7417, DOI 10.1167/iovs.14-15013
- Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212
- Fakin A, 2012, VISION RES, V75, P60, DOI 10.1016/j.visres.2012.08.017
- Grover S, 1998, OPHTHALMOLOGY, V105, P1069, DOI 10.1016/S0161-6420(98)96009-2
- Grover S, 1997, OPHTHALMOLOGY, V104, P460, DOI 10.1016/S0161-6420(97)30291-7
- Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40
- Han ZC, 2011, INVEST OPHTH VIS SCI, V52, P3051, DOI 10.1167/iovs.10-6916
- Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7
- Ho AC, 2015, OPHTHALMOLOGY, V122, P1547, DOI 10.1016/j.ophtha.2015.04.032
- Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045
- Hood DC, 2011, BIOMED OPT EXPRESS, V2, P1097, DOI 10.1364/BOE.2.001097
- Jauregui R, 2018, ASIA-PAC J OPHTHALMO, V7, P183, DOI 10.22608/APO.201851
- MADREPERLA SA, 1990, ARCH OPHTHALMOL-CHIC, V108, P358, DOI 10.1001/archopht.1990.01070050056030
- Rangaswamy NV, 2010, INVEST OPHTH VIS SCI, V51, P4213, DOI 10.1167/iovs.09-4945
- Robson AG, 2012, INVEST OPHTH VIS SCI, V53, P6187, DOI 10.1167/iovs.12-10195
- Schuerch K, 2017, INVEST OPHTH VIS SCI, V58, P1843, DOI 10.1167/iovs.16-21302
- Seiple W, 2004, DOC OPHTHALMOL, V109, P255, DOI 10.1007/s10633-005-0567-0
- Shen S, 2014, OPHTHALMIC GENET, V35, P142, DOI 10.3109/13816810.2014.915328
- Sujirakul T, 2015, AM J OPHTHALMOL, V160, P786, DOI 10.1016/j.ajo.2015.06.032
- Tsang SH, 2008, AM J OPHTHALMOL, V146, P780, DOI 10.1016/j.ajo.2008.06.017
- Wakabayashi T, 2010, ACTA OPHTHALMOL, V88, pE177, DOI 10.1111/j.1755-3768.2010.01926.x